000 | 01182 a2200313 4500 | ||
---|---|---|---|
005 | 20250517151419.0 | ||
264 | 0 | _c20180423 | |
008 | 201804s 0 0 eng d | ||
022 | _a1573-7365 | ||
024 | 7 |
_a10.1007/s11011-017-0015-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCzuba, Ewelina | |
245 | 0 | 0 |
_aCholesterol as a modifying agent of the neurovascular unit structure and function under physiological and pathological conditions. _h[electronic resource] |
260 |
_bMetabolic brain disease _c08 2017 |
||
300 |
_a935-948 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood-Brain Barrier _xmetabolism |
650 | 0 | 4 |
_aBrain Diseases _xmetabolism |
650 | 0 | 4 |
_aCholesterol _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNerve Degeneration _xmetabolism |
650 | 0 | 4 |
_aNeurons _xmetabolism |
700 | 1 | _aSteliga, Aleksandra | |
700 | 1 | _aLietzau, Grażyna | |
700 | 1 | _aKowiański, Przemysław | |
773 | 0 |
_tMetabolic brain disease _gvol. 32 _gno. 4 _gp. 935-948 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11011-017-0015-3 _zAvailable from publisher's website |
999 |
_c27103218 _d27103218 |